| UniProt ID | KCTD5_HUMAN | |
|---|---|---|
| UniProt AC | Q9NXV2 | |
| Protein Name | BTB/POZ domain-containing protein KCTD5 | |
| Gene Name | KCTD5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 234 | |
| Subcellular Localization | Cytoplasm, cytosol. Nucleus. Predominantly cytoplasmic, translocated to the nucleus upon interaction with Rep proteins. | |
| Protein Description | Its interaction with CUL3 suggests that it may act as a substrate adapter in some E3 ligase complex. Does not affect the function of Kv channel Kv2.1/KCNB1, Kv1.2/KCNA2, Kv4.2/KCND2 and Kv3.4/KCNC4.. | |
| Protein Sequence | MAENHCELLSPARGGIGAGLGGGLCRRCSAGLGALAQRPGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAEFYNITSLIKLVKDKIRERDSKTSQVPVKHVYRVLQCQEEELTQMVSTMSDGWKFEQLVSIGSSYNYGNEDQAEFLCVVSKELHNTPYGTASEPSEKAKILQERGSRM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAENHCELL ------CCCCCHHCC | 26.71 | 20068231 | |
| 10 | Phosphorylation | ENHCELLSPARGGIG CCCHHCCCCCCCCCC | 29.19 | 29255136 | |
| 13 | Methylation | CELLSPARGGIGAGL HHCCCCCCCCCCCCC | 47.45 | 115388941 | |
| 26 | Methylation | GLGGGLCRRCSAGLG CCCCHHHHHHHCCHH | 47.91 | 115388947 | |
| 29 | Phosphorylation | GGLCRRCSAGLGALA CHHHHHHHCCHHHHH | 24.45 | 30266825 | |
| 41 | Phosphorylation | ALAQRPGSVSKWVRL HHHCCCCCCCCEEEE | 26.37 | 26552605 | |
| 43 | Phosphorylation | AQRPGSVSKWVRLNV HCCCCCCCCEEEEEC | 23.61 | 26552605 | |
| 57 | Phosphorylation | VGGTYFLTTRQTLCR CCCEEEEECCHHHHC | 15.27 | 20068231 | |
| 67 | Ubiquitination | QTLCRDPKSFLYRLC HHHHCCHHHHHHHHH | 59.12 | 33845483 | |
| 98 | Phosphorylation | LIDRDPTYFGPVLNY ECCCCCCCHHHHHHH | 16.36 | 20068231 | |
| 115 | Ubiquitination | HGKLVINKDLAEEGV CCCEEECHHHHHCCC | 42.89 | 29967540 | |
| 133 | Phosphorylation | AEFYNITSLIKLVKD HHHCCHHHHHHHHHH | 25.05 | 24719451 | |
| 147 | Phosphorylation | DKIRERDSKTSQVPV HHHHHCCCCCCCCCH | 44.01 | 18491316 | |
| 148 | Ubiquitination | KIRERDSKTSQVPVK HHHHCCCCCCCCCHH | 57.39 | 21906983 | |
| 155 | Ubiquitination | KTSQVPVKHVYRVLQ CCCCCCHHHHHHHHH | 22.68 | 27667366 | |
| 191 | Phosphorylation | LVSIGSSYNYGNEDQ EEECCCCCCCCCHHH | 17.69 | - | |
| 193 | Phosphorylation | SIGSSYNYGNEDQAE ECCCCCCCCCHHHHE | 17.07 | - | |
| 223 | Ubiquitination | TASEPSEKAKILQER CCCCHHHHHHHHHHH | 60.35 | 21906983 | |
| 223 | Acetylation | TASEPSEKAKILQER CCCCHHHHHHHHHHH | 60.35 | 25953088 | |
| 225 | Ubiquitination | SEPSEKAKILQERGS CCHHHHHHHHHHHHC | 55.83 | 22817900 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KCTD5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCTD5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCTD5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CUL3_HUMAN | CUL3 | physical | 18573101 | |
| KCTD5_HUMAN | KCTD5 | physical | 18573101 | |
| KCTD5_HUMAN | KCTD5 | physical | 19361449 | |
| GORS2_HUMAN | GORASP2 | physical | 19361449 | |
| NEK6_HUMAN | NEK6 | physical | 21988832 | |
| AAKB2_HUMAN | PRKAB2 | physical | 21988832 | |
| NXF1_HUMAN | NXF1 | physical | 21988832 | |
| ZN711_HUMAN | ZNF711 | physical | 26188516 | |
| MCM7_HUMAN | MCM7 | physical | 26188516 | |
| F193B_HUMAN | FAM193B | physical | 26188516 | |
| NHRF2_HUMAN | SLC9A3R2 | physical | 27173435 | |
| CU002_HUMAN | C21orf2 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10, AND MASS SPECTROMETRY. | |